Iqvia Holdings Inc (IQV) Stock Price, Quote & News

Company Profile

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions th...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 919 998 2000

Website: www.iqvia.com

Address:

2400 Ellis Road, Durham, United States

LevelUpLife Aug. 27 at 10:04 AM

$IQV volatile swings, risk management key here.

0 · Reply

StockAutoPro Aug. 23 at 4:09 PM

$IQV: Buy target $189.15 Sell target $200.71 Consider investing in the health data analytics sector as telemedicine continues to surge in popularity.

0 · Reply

OptionRunners Aug. 21 at 6:45 PM

$IQV Buyer of the December 19th $190 puts (ITM) 1,500 times for $14.70

0 · Reply

UbetMoney Aug. 18 at 3:19 PM

$IQV today’s news about the peace treaty between them and $VEEV will be extremely beneficial to both parties and the pharmaceutical industry even more so. I can see this lifting both companies to the 30 point plus side over the next 3-6 months alone.

0 · Reply

StockAutoPro Aug. 12 at 3:12 AM

$IQV: Buy target $178.09 Sell target $189.09 Consider investing in this leading player in health data and analytics for potential growth.

0 · Reply

NVDAMillionaire Jul. 30 at 8:35 PM

$IQV Really good write-up that perfectly summarizes IQV's present situation. So if you want to bring your IQV knowledge up to date or just discover IQV, this is required reading. https://beyondspx.com/article/iqvia-s-connected-intelligence-powers-through-sector-headwinds-nyse-iqv

0 · Reply

OnlyFibs Jul. 27 at 8:08 PM

$IQV - keep it simple, MOST buy volume EVER on this weekly, chart, you think the party is over, hell to the no, we just getting warmed up, get comfy and watch the show! #hovdid

0 · Reply

JarvisFlow Jul. 25 at 5:34 PM

Mizuho has updated their rating for IQVIA Hldgs ( $IQV ) to Outperform with a price target of 225.

0 · Reply

IN0V8 Jul. 24 at 3:41 PM

$IQV Opportunity Argus Research raises target price to $230 from $180

0 · Reply

Estimize Jul. 24 at 12:03 PM

Wall St is expecting 2.98 EPS for $IQV Q3 [Reporting 10/22 BMO] http://www.estimize.com/intro/iqv?chart=historical&metric_name=eps&utm_cont

0 · Reply

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX MRNA SANA

Aug 19, 2025, 12:00 PM EDT - 11 days ago

The Big 3: BLDR, IQV, LOW

BLDR LOW

Aug 18, 2025, 9:00 AM EDT - 12 days ago

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

VEEV

Jul 22, 2025, 5:40 PM EDT - 5 weeks ago

IQVIA: Q2 Earnings Exceeded My Expectations

Jul 22, 2025, 2:00 PM EDT - 5 weeks ago

IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 8:42 AM EDT - 5 weeks ago

IQVIA beats quarterly estimates on resilient demand for healthcare analytics

Jul 22, 2025, 7:00 AM EDT - 5 weeks ago

IQVIA Reports Second-Quarter 2025 Results

Jul 16, 2025, 7:54 AM EDT - 6 weeks ago

IQVIA: Competition Is Creating More Challenges Over The Long Haul

Jul 1, 2025, 7:00 AM EDT - 2 months ago

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

Jun 16, 2025, 9:00 AM EDT - 2 months ago

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement'

Jun 11, 2025, 7:00 AM EDT - 2 months ago

IQVIA Launches New AI Agents for Life Sciences and Healthcare

Jun 10, 2025, 2:23 PM EDT - 2 months ago

IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?

Jun 2, 2025, 4:37 PM EDT - 3 months ago

IQVIA Announces Pricing of Senior Notes

Jun 2, 2025, 8:10 AM EDT - 3 months ago

IQVIA Announces Offering of Senior Notes

May 27, 2025, 7:00 AM EDT - 3 months ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

RNTX

May 16, 2025, 8:00 AM EDT - 3 months ago

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

May 9, 2025, 1:48 PM EDT - 4 months ago

IQVIA: Q1 Earnings Support Steady Optimism

May 7, 2025, 4:15 PM EDT - 4 months ago

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13

May 6, 2025, 3:04 PM EDT - 4 months ago

IQVIA Holdings Inc. (IQV) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:00 AM EDT - 4 months ago

IQVIA Reports First-Quarter 2025 Results

Apr 28, 2025, 9:00 AM EDT - 4 months ago

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards

Apr 23, 2025, 9:00 AM EDT - 4 months ago

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm

Apr 21, 2025, 4:15 PM EDT - 4 months ago

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

Apr 15, 2025, 8:00 AM EDT - 4 months ago

Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report

Mar 10, 2025, 9:00 AM EDT - 6 months ago

IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services

Mar 4, 2025, 9:00 AM EST - 6 months ago

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

Feb 25, 2025, 3:00 PM EST - 6 months ago

Global Healthy Living Foundation and IQVIA Institute Report Millions of Adult Vaccines Likely Missed When States Restrict Pharmacist Participation

Feb 24, 2025, 9:00 AM EST - 6 months ago

IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence

Feb 21, 2025, 9:00 AM EST - 6 months ago

IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025

Feb 20, 2025, 10:06 AM EST - 6 months ago

IQVIA Releases 2024 Sustainability Report

Feb 16, 2025, 3:36 AM EST - 6 months ago

IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way

Feb 6, 2025, 11:58 AM EST - 7 months ago

IQVIA Holdings Inc. (IQV) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 11:37 AM EST - 7 months ago

IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions

Feb 6, 2025, 8:34 AM EST - 7 months ago

IQVIA beats quarterly results estimates on analytics services demand

Feb 6, 2025, 7:00 AM EST - 7 months ago

IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

Feb 4, 2025, 11:00 AM EST - 7 months ago

IQVIA named to the Fortune® World's Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year

Jan 21, 2025, 4:15 PM EST - 7 months ago

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025

Jan 13, 2025, 9:00 AM EST - 8 months ago

IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions

Dec 23, 2024, 8:00 AM EST - 8 months ago

Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute

Dec 12, 2024, 8:29 AM EST - 9 months ago

IQVIA Holdings: Share Price Disconnected From Growth Outlook

Nov 6, 2024, 4:15 PM EST - 10 months ago

IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024

Oct 31, 2024, 3:52 PM EDT - 10 months ago

IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 12:50 PM EDT - 10 months ago

IQVIA lowers annual revenue forecast amid trial delays

Oct 31, 2024, 7:00 AM EDT - 10 months ago

IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day

Oct 15, 2024, 4:15 PM EDT - 11 months ago

IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024

Oct 2, 2024, 9:00 AM EDT - 11 months ago

IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™

Sep 19, 2024, 9:00 AM EDT - 1 year ago

IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award

Sep 4, 2024, 2:23 PM EDT - 1 year ago

Contract Research Giant IQVIA's Data Assets Are Biggest Differentiator, Provides Best Exposure To AI And Data Opportunities: Analyst

Sep 4, 2024, 9:00 AM EDT - 1 year ago

Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative

Aug 21, 2024, 4:15 PM EDT - 1 year ago

IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024

LevelUpLife Aug. 27 at 10:04 AM

$IQV volatile swings, risk management key here.

0 · Reply

StockAutoPro Aug. 23 at 4:09 PM

$IQV: Buy target $189.15 Sell target $200.71 Consider investing in the health data analytics sector as telemedicine continues to surge in popularity.

0 · Reply

OptionRunners Aug. 21 at 6:45 PM

$IQV Buyer of the December 19th $190 puts (ITM) 1,500 times for $14.70

0 · Reply

UbetMoney Aug. 18 at 3:19 PM

0 · Reply

StockAutoPro Aug. 12 at 3:12 AM

$IQV: Buy target $178.09 Sell target $189.09 Consider investing in this leading player in health data and analytics for potential growth.

0 · Reply

NVDAMillionaire Jul. 30 at 8:35 PM

0 · Reply

OnlyFibs Jul. 27 at 8:08 PM

$IQV - keep it simple, MOST buy volume EVER on this weekly, chart, you think the party is over, hell to the no, we just getting warmed up, get comfy and watch the show! #hovdid

0 · Reply

JarvisFlow Jul. 25 at 5:34 PM

Mizuho has updated their rating for IQVIA Hldgs ( $IQV ) to Outperform with a price target of 225.

0 · Reply

IN0V8 Jul. 24 at 3:41 PM

$IQV Opportunity Argus Research raises target price to $230 from $180

0 · Reply

Estimize Jul. 24 at 12:03 PM

Wall St is expecting 2.98 EPS for $IQV Q3 [Reporting 10/22 BMO] http://www.estimize.com/intro/iqv?chart=historical&metric_name=eps&utm_cont

0 · Reply

YouOnlyLiveTwice Jul. 23 at 8:27 PM

$SPY Today is the beginning of a massive rotation to health care which has been in a bear market for 3 years in light of $IQV and $TMO earnings …many of which have excellent earnings profiles and fortress balance sheets $RVTY …

1 · Reply

JarvisFlow Jul. 23 at 2:48 PM

Truist Securities has adjusted their stance on IQVIA Hldgs ( $IQV ), setting the rating to Buy with a target price of 209 → 235.

0 · Reply

JarvisFlow Jul. 23 at 1:00 PM

Barclays updates rating for IQVIA Hldgs ( $IQV ) to Equal-Weight, target set at 165 → 185.

0 · Reply

JarvisFlow Jul. 23 at 1:00 PM

Baird has updated their rating for IQVIA Hldgs ( $IQV ) to Neutral with a price target of 196.

0 · Reply

LordWellesley Jul. 23 at 4:10 AM

Experts call for action to fulfil the potential of real-world data in pharma research $IQV $ICLR $MDRX https://becarispublishing.com/digital-content/blog-post/experts-call-action-fulfil-potential-real-world-data-research

0 · Reply

CautiousInvestor538 Jul. 23 at 12:05 AM

$IQV short

0 · Reply

RunnerSignals Jul. 22 at 7:45 PM

$IQV We scanned before the +19% move and shared it while it was setting up. It’s a good reminder to watch what the scanner flags - cause these moves can happen fast

0 · Reply

topstockalerts Jul. 22 at 6:33 PM

$IQV primed for continuation.. ✅📈 Stay tuned bulls!!

0 · Reply

topstockalerts Jul. 22 at 6:32 PM

$IQV showing high relative strength.. Stay tuned for more!👀👀

0 · Reply

ZacksResearch Jul. 22 at 6:01 PM

$IQV beats Q2 earnings & revenue — but slashes 2025 EBITDA guidance ⚠️ Earnings rose 6.4% and revenue climbed 5.5% year over year, topping estimates... yet the full-year EBITDA outlook gets trimmed. Dig into the mixed setup here 👉 https://www.zacks.com/stock/news/2604192/iqvia-earnings-revenues-beat-estimates-in-q2-rise-yy?cid=sm-stocktwits-2-2604192-teaser-3180&ADID=SYND_STOCKTWITS_TWEET_2_2604192_TEASER_3180

0 · Reply

YouOnlyLiveTwice Jul. 22 at 5:42 PM

$TMO This is pinballing higher due to the $IQV ER w regard to their health care analytics line Thermo doesn’t have one but $RVTY has one…called Signal which is growing @ 20% …

0 · Reply

ZacksResearch Jul. 22 at 4:15 PM

$IQV beats Q2 estimates, but the stock is down 14.3% YTD — time to rethink this hold? 🤔 📈 EPS of $2.81 tops estimates by 1.8%, with revenue up 5.3% from the year-ago quarter 📊 Technology & Analytics segment shines with 8.9% growth from the year-ago quarter 🔄 Guidance tweaked: Revenue outlook up, but EBITDA guidance trimmed Opportunity assessment here 👉 https://www.zacks.com/stock/news/2604192/iqvia-earnings-revenues-beat-estimates-in-q2-rise-yy?cid=sm-stocktwits-2-2604192-body-3122&ADID=SYND_STOCKTWITS_TWEET_2_2604192_BODY_3122

0 · Reply

Market Cap	32.10B
Revenue (ttm)	15.41B
Net Income (ttm)	1.37B
EPS (ttm)	N/A
PE Ratio	18.14
Forward PE	17.59
Profit Margin	8.91%
Debt to Equity Ratio	2.68

Volume	1,089,300
Avg Vol	1,912,808
Day's Range	N/A - N/A
Shares Out	170.00M
Stochastic %K	51%
Beta	1.30
Analysts	Strong Sell
Price Target	$214.19